Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 94944-69-1 | MDL No. : | MFCD11112281 |
Formula : | C13H17NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NDGWBAFATMSBHZ-LBPRGKRZSA-N |
M.W : | 235.28 g/mol | Pubchem ID : | 6932653 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 67.78 |
TPSA : | 49.77 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.68 cm/s |
Log Po/w (iLOGP) : | 2.69 |
Log Po/w (XLOGP3) : | 1.49 |
Log Po/w (WLOGP) : | 1.25 |
Log Po/w (MLOGP) : | 1.41 |
Log Po/w (SILICOS-IT) : | 1.38 |
Consensus Log Po/w : | 1.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.23 |
Solubility : | 1.37 mg/ml ; 0.00583 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.14 |
Solubility : | 1.69 mg/ml ; 0.0072 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.42 |
Solubility : | 0.901 mg/ml ; 0.00383 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.67 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With recombinant Rhodococcus erythropolis DSM 43297 ketoredutase; nicotinamide adenine dinucleotide In aq. phosphate buffer; isopropyl alcohol at 50℃; for 1.5 h; Enzymatic reaction | General procedure: The reaction mixture containing 200 mM substrate, 1mM NAD+, 5percent (v/v) 2-propanol and 10mg crude enzyme READH in 1mL potassium phosphate buffer (100mM, pH 7.0) was incubated at 50 °C. For ChKRED20, 40percent (v/v) 2-propanol and a reaction temperature of 40 °C were applied instead. The reaction was monitored by TLC, and terminated by extracting with methyl tert-butyl ether (1 mL). The organic extract was dried over anhydrous sodium sulfate and concentrated. The samples were subjected to chiral HPLC to determine the conversion and enantiomeric excess. The products were purified by silica gel column chromatography, and identified by NMR analysis, optical rotation measurements and mass spectrometry. |
[ 253782-22-8 ]
(R)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 1932807-60-7 ]
(S)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 167096-99-3 ]
Benzyl (3S,4R)-3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 167097-00-9 ]
(3R,4R)-rel-Benzyl 3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 1314396-07-0 ]
Benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate
Similarity: 0.97
[ 253782-22-8 ]
(R)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 1932807-60-7 ]
(S)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 167096-99-3 ]
Benzyl (3S,4R)-3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 167097-00-9 ]
(3R,4R)-rel-Benzyl 3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 1314396-07-0 ]
Benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate
Similarity: 0.97
[ 253782-22-8 ]
(R)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 1932807-60-7 ]
(S)-Benzyl 3-hydroxyazepane-1-carboxylate
Similarity: 0.98
[ 167096-99-3 ]
Benzyl (3S,4R)-3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 167097-00-9 ]
(3R,4R)-rel-Benzyl 3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 1314396-07-0 ]
Benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate
Similarity: 0.97
[ 167832-41-9 ]
trans-Benzyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.95
[ 95656-88-5 ]
Benzyl 3-hydroxypyrrolidine-1-carboxylate
Similarity: 0.91
[ 100858-32-0 ]
Benzyl (S)-3-hydroxypyrrolidine-1-carboxylate
Similarity: 0.91
[ 100858-33-1 ]
Benzyl (R)-3-hydroxypyrrolidine-1-carboxylate
Similarity: 0.91
[ 95798-23-5 ]
Benzyl 4-hydroxypiperidine-1-carboxylate
Similarity: 0.91
[ 167096-99-3 ]
Benzyl (3S,4R)-3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 167097-00-9 ]
(3R,4R)-rel-Benzyl 3,4-dihydroxypiperidine-1-carboxylate
Similarity: 0.97
[ 1314396-07-0 ]
Benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate
Similarity: 0.97
[ 959617-87-9 ]
(3R,4R)-Benzyl 4-amino-3-hydroxypiperidine-1-carboxylate
Similarity: 0.95
[ 1241922-22-4 ]
Benzyl 3-methoxypiperidine-1-carboxylate
Similarity: 0.95